TAUTOMERIC PHENOMENON OF FK506 IN SOLUTION

被引:0
|
作者
NAMIKI, Y [1 ]
KIHARA, N [1 ]
FUJIOKA, M [1 ]
SHIMATANI, K [1 ]
FUJIWARA, A [1 ]
HANE, K [1 ]
YASUDA, T [1 ]
机构
[1] FUJISAWA PHARMACEUT CO LTD,ANALYT RES LABS,OSAKA 532,JAPAN
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:72 / ANYL
相关论文
共 50 条
  • [31] FK506研究进展
    唐功耀
    鲍镇美
    临床泌尿外科杂志, 1993, (02) : 118 - 121
  • [32] Comparison of FK506 and cyclosporine - Reply
    Gjertson, DW
    Cecka, JM
    TRANSPLANTATION, 1996, 62 (05) : 702 - 702
  • [33] HEPATOTROPHIC EFFECTS OF FK506 IN DOGS
    STARZL, TE
    PORTER, KA
    MAZZAFERRO, V
    TODO, S
    FUNG, J
    FRANCAVILLA, A
    TRANSPLANTATION, 1991, 51 (01) : 67 - 70
  • [34] 肾移植与FK506
    周吉海,谭季春
    日本医学介绍, 1994, (06) : 269 - 270
  • [35] Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506
    Kotaka, Masayo
    Ye, Hong
    Alag, Reema
    Hu, Guangan
    Bozdech, Zbynek
    Preiser, Peter Rainer
    Yoon, Ho Sup
    Lescar, Julien
    BIOCHEMISTRY, 2008, 47 (22) : 5951 - 5961
  • [36] FK506的肾毒性
    祖强
    姚冰
    于立新
    肾脏病与透析肾移植杂志, 2000, (03) : 251 - 253
  • [37] PANCREATICODUODENAL ALLOTRANSPLANTATION WITH CYCLOSPORINE AND FK506
    SATO, K
    YAMAGISHI, K
    NAKAYAMA, Y
    YOKOTA, K
    UCHIDA, H
    MASAKI, Y
    WATANABE, K
    ASO, K
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1074 - 1075
  • [38] COMPARATIVE STUDIES OF FK506 WITH CYCLOSPORINE
    HEWITT, CW
    BLACK, KS
    TRANSPLANTATION, 1988, 46 (03) : 482 - 483
  • [39] MODEL FOR PREDICTION OF FK506 DOSING
    STEINMULLER, DR
    FITZSIMMONS, WE
    SELF, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 181 - 181
  • [40] INTERACTION BETWEEN FK506 AND ERYTHROMYCIN
    SHAEFFER, MS
    COLLIER, D
    SORRELL, MF
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (02) : 280 - 281